What happens in North Korea - always remains shrouded in mystery. Pyongyang insists it has no Wuhan virus cases. Then, why did it try to steal vaccine data from US pharma company Pfizer? WION's Palki Sharma brings you a report.

Gravitas: Did North Korea try to steal data from Pfizer?

Millions of COVID-19 vaccine doses are going to get wasted in large as Japan struggles to secure special syringes. Production has been impacted at a large scale while manufacturers are looking for ways to ramp up production of the syringes. The country signed a contract with Pfizer of 144 million doses for 72 million people.

Japan faces shortage of special syringes

Moderna and Pfizer vaccine's slow roll-out has affected the vaccination program in Canada. So, now Canada has placed a request for about a million doses of COVID-19 vaccine from India's Serum Institute.

Slow vaccine roll-out in Canada affects inoculation, asks India for COVID-19 Vaccine supply

South Africa faces a serious setback as scientists and experts announced that AstraZeneca vaccine is less effective against 501.Y.V2 covid variant first found in South Africa.

South Africa halts AstraZeneca vaccinations over variant data

Vaccine Manufacturer Pfizer on Friday withdraws its application from India. Pfizer vaccine was the first to get the emergency use authorization in India. This decision has come after reportedly failing to meet the drug regulator demand for local safety and immunogenicity study. So this decision means vaccines will not be available for sale in the world's second-most populous nation.

Pfizer drops India Vaccine Application, fail to meet drug regulators demand

Pharma major Pfizer on Friday said it has decided to withdraw its application for Emergency Use Authorisation (EUA) of its COVID-19 vaccine in India. Pfizer was the first pharmaceutical firm to seek an emergency use authorisation from the Drugs Controller General of India (DCGI) for its COVID-19 vaccine in the country, after it secured such clearance in the UK and Bahrain.

COVID-19 vaccine: Pfizer withdraws Emergency Use Authorisation application in India

Pfizer withdraws Emergency Use Authorisation application in India

Swiss pharmaceuticals giant Novartis has signed an initial agreement to help produce the Pfizer-BioNTech vaccine against Covid-19, as countries scramble to boost supplies.

Novartis to help make Pfizer-BioNTech Covid vaccine

China failed to export vaccines to the world, so it is now exporting a smear campaign. Beijing is targeting Pfizer, Moderna vaccines. WION's Molly Gambhir tells you how.

Gravitas: China starts a smear campaign

The US will be purchasing 200 million more doses of Coronavirus vaccines as it tries to boost its inoculation drive. President Joe Biden has said that Americans can beat the pandemic if enough people are vaccinated.

US to purchase more Pfizer and Moderna doses

In recent weeks, the European Union countries have faced a delay in the delivery of the coronavirus vaccines which has raised alarms. The delay has been caused as the Pfizer-BioNTech has not been able to supply the promised doses.

EU chief says companies 'must deliver' coronavirus vaccines; Germany agrees

On Monday, Australia approved the Pfizer-BioNTech coronavirus vaccine for use. Australia's Prime Minister Scott Morrison on Monday said that the country's medical regulator was among the first globally to finish the approval of Pfizer-BioNTech vaccine.

Australia approves Pfizer-BioNTech's coronavirus vaccine

Italian Prime Minister Giuseppe Conte lashed out at suppliers of COVID-19 vaccines on Saturday, saying delays in deliveries amounted to a serious breach of contractual obligations.

Italian PM says vaccine delays 'unacceptable', threatens to sue Pfizer

The delivery of the Pfizer vaccine has fallen by 15% this week. It is expected to drop by 30% in February. Countries are now bracing for a shortage. Palki Sharma Upadhyay tells you why the deliveries of the shots are delayed.

Gravitas: Pfizer vaccine: Governments feel the pinch of shortages

Just a day after Pfizer slashed the supply of COVID-19 vaccines to Europe, AstraZeneca has also taken a similar step by slashing the supply by 60%.

After Pfizer, Astrazeneca cuts down the supply to EU by 60%

An organisation, led by doctors, in Britain has expressed apprehension about the decision to give people a second dose of coronavirus vaccine up to 12 weeks after the first, rather than the shorter gap recommended by manufacturers and the World Health Organisation.

Doctors in Britain want review of Pfizer shots' timetable

The World Health Organization (WHO) said that there is no evidence to substantiate that Pfizer-BioNTech's coronavirus vaccine has contributed to the deaths of the elderly and called for the use of the jab.

WHO says Pfizer's vaccine safe to use as concerns rise post-Norway deaths

Most medical experts agree that vaccines are not silver bullets and the events in recent days further corroborate this theory. In Israel, more than 12,000 people tested positive despite receiving the shot.

Pfizer-BioNTech's vaccine raised hopes, but supply, efficacy concerns are hurting

Last week, 29 people died after being administered Pfizer-BioNtech coronavirus vaccine in Norway. Following the incident, the Australian Health Minister has demanded detailed information of the incident on an urgent basis.

Norway: Australia demands information after 29 die following COVID-19 vaccine

Pfizer-BioNTech's coronavirus vaccine is effective against the new strains of COVID-19, found in the UK and South Africa, a laboratory study conducted by the US drugmaker confirmed on Friday.

Pfizer-BioNTech vaccine effective against new dangerous variant: Study

A few weeks after the European Union approved the Pfizer-BioNtech vaccine for emergency use in the union, the German pharmaceutical company BioNtech has lashed out at the EU for not approving enough doses.

BioNTech lashes out at EU for not ordering enough COVID-19 vaccine

Vaccine expert committee in India met today. Dry run for coronavirus vaccination in India is on January 2. Watch this video to know more.

India: Dry run for coronavirus vaccination on January 2

Drugmakers, including Pfizer, Sanofi SA, and others are mulling over plans to hike prices of more than 300 drugs in the US on January 1, a report based on drugmakers and data analysed by medical research firm 3 Axis Advisors.

Drug prices to hike in 2021 as pandemic jolts revenues: Report

The United States has reported a record number of deaths from COVID-19, as the worst outbreak in the world shows little sign of easing. With a patient in California also confirmed to have the British variant of the virus, the country is also considering requiring COVID tests from passengers from more countries as early as next week.

US records highest coronavirus daily death toll since pandemic started 

pfizer

Pfizer, News on Pfizer, stories on Pfizer, articles on Pfizer, Pfizer stories at Wion, Pfizer news, Pfizer latest news